secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-09-08T12:35:36+00:00
Accession:  0001140361-26-035853
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech raises up to $22.55M in PIPE led by Nant; Soon-Shiong to join board
-------------------------------------------------------------------------------

- PIPE raises up to $22.55M: $11.55M initial closing at $0.2825/unit, plus $11M milestone (Nant $10M, AB Group $1M) upon Phase 3 protocol submission.
- Nant Capital led; Dr. Patrick Soon-Shiong to join board; Nant gets right to designate 2 directors while owning ≥15%.
- Proceeds to repay debt and fund development; PDS0301 Phase 2 data in MSS/pMMR mCRC showed 80% survival at 24 months.
- Company grants NantWorks 1-year exclusive option to negotiate license for PDS0101; board expands from 6 to 8.
- Common warrants exercisable at $0.22/share for 1 year; pre-funded warrants at $0.00033; 19.9% beneficial ownership cap.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126035853/0001140361-26-035853-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126035853/ef20081705_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-035853

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer